A digital twin of glimepiride for personalized and stratified diabetes treatment
This digital twin provides mechanistic insights into pharmacokinetic variability and serves as an <i>in silico</i> platform for exploring individualized dosing and patient stratification strategies, laying the foundation for clinical decision support tools to improve T2DM management.
Authors
- Matthias König (ORCID: https://orcid.org/0000-0003-1725-179X)
- Michelle Elias (ORCID: https://orcid.org/0009-0005-7959-3164)
Institutions
- Humboldt-Universität zu Berlin (DE)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-10-08
- DOI
- https://doi.org/10.3389/fphar.2025.1686415
- Citations
- 2
- Primary Topic
- Pharmacogenetics and Drug Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 3.11